Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2018 DISEASE NETWORK PROJECTS LOGIN
 
 
  
Pathogenic mechanisms -
--->Uutiset
[-]Projekti
--->Rahoittaja
--->[+]Johtokunta
--->[+]Writing Committee Strategic ...
--->[+]Neuvoa antava lautakunta
--->Keskuskoordinaatio
--->Kielikoordinaatio
--->Fellowship Programme
--->[+]Perustuslaki 2008
--->[-]Jäsenet
--->Jäsenyyden hakeminen
[-]Tutkimuspaikat
--->[+]Itävalta
--->[+]Belgia
--->[-]Tsekin tasavalta
--->[+]Coordination
--->[+]HD Associations
--->Brno
--->Ostrava
--->Olomouc
--->Prague
--->[+]Tanska
--->[+]Suomi
--->[+]Ranska
--->[-]Saksa
--->Coordination
--->HD Associations
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Kontakte
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Marburg-Uni
--->[+]Lübeck
--->Marburg-KPP
--->Mainz
--->Munich
--->München-LMU
--->Münster
--->Rostock
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[-]Italia
--->Coordination
--->HD Associations
--->Bari
--->Bologna
--->Brescia
--->Cagliari
--->Florence
--->Genoa
--->Milan
--->Napels
--->Pisa
--->Pozzilli
--->Rome
--->Rome-LIRH
--->Rome-Sant'Andrea
--->[-]Alankomaat
--->Coordination
--->HD Associations
--->Enschede
--->Groningen
--->Leiden
--->[+]Maastricht
--->Nijmegen
--->[+]Norja
--->[+]Puola
--->[+]Portugali
--->[+]Russia
--->[-]Espanja
--->Coordination
--->[+]Meeting 2008
--->[+]Meeting 2009
--->[+]Meeting 2010
--->[-]Meeting 2011
--->Documents
--->[+]Meeting 2012
--->[+]Meeting 2013
--->HD Associations
--->Alicante
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Bilbao
--->Burgos
--->Canaries
--->Granada
--->Fuenlabrada
--->[+]Madrid-BTCIEN
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Santiago
--->Sevilla
--->Sevilla-HUVRocio
--->Sevilla-St-Ana
--->Valencia
--->Zaragoza
--->[+]Ruotsi
--->[+]Sveitsi
--->[-]Iso-Britannia
--->Coordination
--->HD Associations
--->Links
--->[-]UKHDN
--->Member Sites
--->Activities
--->News
--->Meetings
--->Research prog
--->Documents
--->Standard of Care
--->Aberdeen
--->[+]Ayr
--->Belfast
--->Birmingham
--->[+]Blandford Forum
--->Bristol
--->Cambridge
--->Cardiff
--->Dundee
--->Edinburgh
--->Exeter
--->Fife
--->Forth Valley
--->Glasgow
--->Gloucester
--->Hull
--->Inverness
--->Launceston
--->Leeds
--->Leicester
--->Liverpool
--->London - Guy's Hospital
--->London - Hammersmith
--->London - NHNN
--->London - Royal Hospital
--->London - St. George´s
--->[+]Documents
--->Manchester
--->Newcastle-Upon-Tyne
--->[+]Northampton
--->Nottingham
--->Oxford
--->[+]Plymouth
--->Poole
--->Preston
--->Reading
--->[+]Sheffield
--->Southampton
--->Stoke-on-Trent
--->Swindon
--->Wrexham
--->[+]Outside Europe
[-]Työryhmät
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[-]Biomarkers
--->[-]Päivämäärät
--->[+]Meetings
--->[+]Brainbanking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juveniili Huntingtonin tauti
--->[+]Motor Phenotype
--->[+]Neuroprotective Rx
--->[+]Physiotherapy
--->[-]Quality of Life
--->[+]Päivämäärät
--->[-]Meetings
--->Meeting 2005/03
--->Meeting 2005/09
--->Meeting 2006/07
--->Meeting 2006/12
--->Meeting 2007/09
--->Meeting 2008/08
--->Meeting 2008/09
--->Meeting 2009/11
--->Meeting 2010/05
--->Meeting 2016/09
--->Meeting 2017/07
--->[+]Standard of Care
--->[+]Surgical Therapy
--->[+]Symptomatic Rx
--->[+]Young Adults
[-]Tapahtumat
--->[-]EHDN 2018
--->Announcement
--->Introduction
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Registration
--->Photos
--->Sponsoring/Partners
--->CME points
--->HD on the Move
--->Travel Information
--->Hotel booking
--->Flight booking
--->ACV Security Checks
--->About Vienna
--->Useful information
--->Contacts
--->Reimbursement
--->[+]Abstract Submission
--->Documents
--->Feedback
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[+]Overduin Registration
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[-]EHDN 2010
--->Introduction
--->Programme I
--->Programme II
--->Additional Meetings
--->Registration
--->EHA Programme
--->[+]EHA Registration
--->Plenary Dinner
--->Social Programme
--->Important Dates
--->[+]Abstract Submission
--->Reimbursement
--->Hotel Booking
--->[+]Travel and Location
--->[+]About Prague
--->Documents
--->Committees
--->Contact
--->Feedback & Evaluation
--->[+]EHDN 2008
--->[-]EHDN 2007
--->Final Programme
--->Additional Meetings
--->Meeting Venue
--->[+]About Dresden
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Final Programme
--->Plenary Dinner
--->Registration
--->Working Groups
--->Meeting Venue
--->Manchester
--->Evaluation & Feedback
--->[+]EHDN 2004
[+]Yhteydenpito
--->Työtarjoukset
päivämääräkuvauskokokirjoittaja asiakirja 
06.12.12A framework for cross-species data integration, model sensitivity analysis and target prioritisation in Huntington’s disease using bionetworks1.4 MBblankinapplication/pdfb01-framework-cross-species-data-integ... 
06.12.12Huntington’s disease and its therapeutic target genes: a global functional profile based on the HD research crossroads database1.1 MBblankinapplication/pdfb02-huntington’s-disease-and-its-thera... 
06.12.12Systematic interactome mapping: understanding the molecular principles of neurodegenerative diseases2.1 MBblankinapplication/pdfb03-systematic-interactome-mapping 
06.12.12AMPK activation alleviates phenotypes associated to the early phases of mutant polyQ cytoxicity1.6 MBblankinapplication/pdfb04-ampk-activation 
06.12.12CAG profiling in R6/1 89Q indicates early and progressive expansion in critical neuronal populations and expansion and changes in surrounding glial cell populations2.1 MBblankinapplication/pdfb05-cag-profiling-in-r61-89q 
06.12.12Genotoxic stress in fibroblasts and mesenchymal stem cells isolated from miniature pigs transgenic for n-terminal part of mutated human huntingtin1.3 MBblankinapplication/pdfb06-genotoxic-stress-fibroblasts-mesen... 
06.12.12Analysis of Huntingtin protein fragments in post mortem human Huntington's Disease brain tissue1.8 MBblankinapplication/pdfb07-protein-fragments-post-mortem-human 
06.12.12Differential sensitivity of aggregate markers in HdhQ150 and YAC128 HD mouse models1.6 MBblankinapplication/pdfb08-differential-sensitivity-of-aggreg... 
06.12.12Caspase-6 does not contribute to the proteolysis of mutant Huntingtin in the HDHQ150 knock-in mouse model of Huntington's Disease1.5 MBblankinapplication/pdfb09-caspase-6 
06.12.12The role of N-terminal phosphorylation in Huntingtin´s oligomerization, aggregation and toxicity2.0 MBblankinapplication/pdfb10-n-terminal-phosphorylation 
06.12.12HDAC4 interacts with Huntingtin and HDAC4 reduction decreases cytoplamsic aggregation and rescues synaptic dysfunction in HD mouse models1.6 MBblankinapplication/pdfb11-hdac4-interacts-with-huntingtin 
06.12.12Long-term alterations in dendritic spine stability in Huntington Disease: Mechanisms underlying learning deficits in Huntington Disease?687 kBblankinapplication/pdfb12-mechanisms-underlying-learning-def... 
06.12.12Huntingtin mediates anxiety/depression-related behaviors in mouse through BDNF transport and hippocampal neurogenesis1.6 MBblankinapplication/pdfb15-bdnf-transport-hippocampal-neuroge... 
06.12.12CTCF in Huntington’s Disease2.0 MBblankinapplication/pdfb16-ctcf-in-hd 
06.12.12Collapsin response mediator protein 4 downregulates aggregation and toxicity of mutant huntingtin1.5 MBblankinapplication/pdfb17-collapsin-response-mediator-protei... 
06.12.12Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation1.6 MBblankinapplication/pdfb18-delaying-aging-and-aging-associate... 
06.12.12Glucose metabolism is reduced in Huntington Disease: in-vivo and in-vitro evidence559 kBblankinapplication/pdfb19-glucose-metabolism 
06.12.12Lactate metabolism in the Huntington's Disease mouse model R6/21.7 MBblankinapplication/pdfb20-lactate-metabolism 
06.12.12Increased glucose uptake in white adipose tissue of R6/2 mice due to changes in expression and translocation of glucose transporter 4 (GLUT4)1.7 MBblankinapplication/pdfb21-increased-glucose-uptake-white-adi... 
06.12.12Decreased expression and reduced translocation to the sarcolemma of the insulin-sensitive glucose transporter GLUT4 in skeletal muscle of R6/2 mice1.4 MBblankinapplication/pdfb22--reduced-translocation-sarcolemma 
06.12.12Does a peripheral immune response influence muscle pathology in Huntington’s Disease?1.6 MBblankinapplication/pdfb23-peripheral-immune-response-muscle-... 
06.12.12Immune dysfunction in HD human myeloid cells is caused by NFkB pathway dysregulation and is reversed by lowering HTT levels1.1 MBblankinapplication/pdfb24-immune-dysfunction-in-hd-human-mye... 
06.12.12Dysfunctional dopaminergic neurones and biphasic activitydependent dopamine release in mouse models of Huntington’s Disease1.5 MBblankinapplication/pdfb25-dysfunctional-dopaminergic-neurone... 
06.12.12Hyperdopaminergic status in Huntington's Disease1.6 MBblankinapplication/pdfb26-hyperdopaminergic-status-in-hd 
06.12.12Sleep and EEG abnormalities in Huntington’s Disease mice1.6 MBblankinapplication/pdfb27-sleep-and-eeg-abnormalities 
06.12.12Neural mechanisms underlying the dysfunction of the methamphetamine-sensitive circadian oscillator (MASCO) in a mouse model of Huntington’s Disease2.1 MBblankinapplication/pdfb29-neural-mechanisms-dysfunction-masco 
06.12.12Voluntary exercise improves circadian function in a mouse model of Huntington’s Disease1.5 MBblankinapplication/pdfb30-circadian-function-in-mouse-model 
06.12.12Expression of mutant Huntingtin in leptin receptorexpressing neurons does not influence the metabolic phenotype and psychiatric-like features in Huntington’s Disease1.6 MBblankinapplication/pdfb31-expression-of-mutant-huntingtin-le... 
06.12.12Deletion of mutant Huntingtin expression in Sim1 neurons in the BACHD mouse model of Huntington's Disease1.5 MBblankinapplication/pdfb32-deletion-of-mutant-huntingtin-expr... 
06.12.12Copy number variation of the neuronal glucose transporter 3 and age of onset in Huntington’s Disease1.5 MBblankinapplication/pdfb0x-neuronal-glucose-transporter-3 
06.12.12Components of the translational machinery modify toxicity in models of Huntington’s Disease1.5 MBblankinapplication/pdfb0y-translational-machinery-modify-tox... 

Kansio sisältää 31 asiakirjaa.
about us | privacy statement | disclaimer | terms of use